$TTNP - Titan Pharmaceuticals Shares Down 52% on Public Offering TTNP 11:00 AM ET 10/16/19 | Dow Jones By Chris Wack Shares of Titan Pharmaceuticals Inc. (TTNP) dropped 52%, to 18 cents, after the company said a public offering priced Wednesday. The commercial-stage therapeutics company said an underwritten public offering of 40 million units priced to the public at 22.5 cents a unit. Titan said each unit issued in the offering consists of one share of common stock and one Class B Warrant to purchase one share of common stock. The company said gross proceeds are expected to be $9 million. The Class B Warrants will be immediately exercisable at a price of 22.5 a share of common stock and will expire five years from the date of issuance. The offering is expected to close on or about Oct. 18. Write to Chris Wack at chris.wack@wsj.com > Dow Jones Newswires October 16, 2019 11:00 ET (15:00 GMT) Copyright (c) 2019 Dow Jones & Company, Inc.